Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples